SEAL brain health under scrutiny: new study aims to detect hidden blast injuries
NCT ID NCT07131475
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 100 active-duty Navy SEALs over 4 years to see if repeated exposure to blasts affects their brain health. Researchers will use brain scans and blood tests to look for early signs of injury. The goal is to develop a way to detect blast-related brain damage before symptoms appear.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PBR28 TSPO PET (a radioactive tracer for brain imaging)
What this could lead to
If successful, this could lead to a reliable diagnostic test to detect early brain injury from blasts, helping protect special operations forces.
What could go wrong
This is a small, early-phase study (100 people) focused on observation, not treatment. The biomarkers may not prove useful for diagnosis, and results may not apply to other groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLAST INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••